[REGN] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
08-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 36.47%
YoY- 45.10%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 3,452,800 5,138,500 2,528,700 2,422,900 2,294,000 1,952,000 1,828,200 52.73%
PBT 1,816,600 3,752,800 1,253,000 1,224,600 998,300 918,900 668,600 94.59%
Tax 184,400 653,900 137,800 75,400 156,200 21,600 44,000 159.71%
NP 1,632,200 3,098,900 1,115,200 1,149,200 842,100 897,300 624,600 89.60%
Tax Rate -10.15% -17.42% -11.00% -6.16% -15.65% -2.35% -6.58% -
Total Cost 1,820,600 2,039,600 1,413,500 1,273,700 1,451,900 1,054,700 1,203,600 31.73%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 47.27 60.31 44.10 47.43 36.71 45.97 34.16 24.15%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS 15.37 29.51 10.58 10.90 7.98 8.19 5.69 93.84%
EPS Diluted 14.33 27.97 10.09 10.24 7.39 7.61 5.43 90.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.